NSEUpdates10 Sept 2026 · 10 Sept 2026, 04:02 pm

Updates

Nureca Limited · NURECA

✦ AI SummaryRelated Party

Nureca Limited has made a disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, regarding a designated person acquiring/purchasing shares of the company.

Analysis Scores

Earnings Impact1/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations)'.

Attachments (1)

📄

NURECA_10092026160202_StockExchnageIntimationFormCSMG10092026Signed.pdf

pdf

Download →
View document text
www.nureca.com Dated: September 10, 2026 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA LIMITED Corporate Relations Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. C/1 Dalal Street, Fort G Block, Bandra Kurla Complex, Bandra (E) Mumbai-400001 Mumbai-400051 Scrip code: 543264 Scrip Code: NURECA Subject: Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”) Dear Sir/Madam, This is to inform you that a designated person of the Company has acquired/purchased shares of the Company and, being a designated person, the transaction is covered under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, read with the applicable provisions relating to automation of continual disclosures/system- driven disclosures under the said Regulations. Pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, we hereby submit the disclosure received from Ms. Smita Goyal, a member of the Promoter Group of Nureca Limited, in the prescribed Form C, in respect of the transaction in the securities of the Company. Kindly take the same on record. Thanking you, For Nureca Limited Nishu Kansal Company Secretary & Compliance Officer M. No.: A33372 NURECA LIMITED Correspondence Office: SCO 6-7-8, 1st Floor, Madhya Marg, Sector 9-D, Chandigarh, India - 160009 Registered Office: Andheri West B-205, Bldg -42, B wing, Dhanashree heights, Azad Nagar Sangam CHS, Andheri West, Mumbai – 400053 Phone No. +91-172-5292900, CIN: L24304MH2016PLC320868